Paul Bunn, MD

University of Colorado

• Helped set the standards for the treatment and diagnosis of lung cancer
• Chaired the FDA Oncology Drug Advisory Committee
• Listed in Marquis’ *Who’s Who in America*

David Garfield, MD

University of Colorado Comprehensive Cancer Center

• Trained by Dr. BJ Kennedy, the father of Medical Oncology
• Author of nearly 70 publications
• A founder of U.S. Oncology
• Associate Medical Director of ProMed Cancer Centers, Shanghai, China from 2010 - 2013

Janice Dutcher, MD

Cancer Research Foundation of New York

• Past-Chair of the FDA Oncology Drug Evaluation Committee
• Co-Chair of the National Cancer Institute Renal Cancer Task Force
• Listed in Marquis’ *Who’s Who* as well as *Checkbook’s* “Top Docs”

Mitchell Posner, MD

The University of Chicago Medicine

• As the recipient of dozens of awards, he continues to be recognized for his many accomplishments in his field
• Current Chairman of the Gastrointestinal Committee of the American College of Surgeons Oncology
• Group and Past President of the Society for Surgical Oncology
• Has published more than 200 articles, abstracts, and book chapters discussing his areas of specialty

Kenneth Tanabe, MD

Massachusetts General Hospital

• Research supported by the National Institutes of Health—continuously—for the past 23 years
• Developer of several engineered viruses that effectively destroy liver tumors
• First in identifying and demonstrating several crucial clinical breakthroughs

E. David Crawford, MD

University of Colorado School of Medicine

• Internationally recognized expert in urologic cancers
• Author or coauthor of over 600 scientific articles, 7 textbooks, and more than 50 book chapters
• Rated one of the top 20 urologists in the United States, for men, by Men’s Health Magazine

Sagar Lonial, MD, FACP

Winship Cancer Institute

• Winner of numerous awards in his field and author of more than 200 scientific articles
• Serves on the editorial boards of the Journal of Clinical Oncology and Leukemia
• Myeloma Editor for Clinical Lymphoma, Myeloma, and Leukemia

I. Craig Henderson, MD

UCSF Helen Diller Family Comprehensive Cancer Center

• Served as PI of the pivotal trial on the importance of paclitaxel for early breast cancer
• Past Chairperson of the Oncologic Drugs Advisory Committee, FDA
• Recently wrote an essential single-author textbook about breast cancer

Hope Rugo, MD

UCSF Helen Diller Family Comprehensive Cancer Center

• 2010 recipient of the Cancer Care Physician of the Year Award
• Recipient of the prestigious Susan G. Komen Promise Award
• Serves as an investigator and as a member of steering committees for several important national and international trials

William John Gradishar, MD

Robert H. Lurie Comprehensive Cancer Center

• Program Director of the Hematology Oncology Fellowship Training Program at Northwestern
• Founding Editor-in-Chief of NEJM Journal Watch Hematology/Oncology
• Chair of the Breast Cancer Working Group/Moonshot 2020

Henry Friedman, MD

The Preston Robert Tisch Brain Tumor Center

• Author of more than 500 peer-reviewed articles, reviews, and book chapters
• Senior Editor of CNS Oncology
• Recognized with many important awards, including the Visionary Award from the Tug McGraw Foundation

Alan Venook, MD

UCSF Helen Diller Family Comprehensive Cancer Center

• International leader in gastrointestinal cancers
• Member of the National Cancer Institute Colorectal taskforce
• Listed in *Castle Connolly’s* “America’s Top Doctors”

Patrick Wen, MD

Dana Farber Cancer Institute, Harvard University

• Internationally renowned neurologist
• Co-Director of the National Cancer Institute-supported Adult Brain Tumor Consortium
• Listed in *Castle Connolly’s* “America’s Top Doctors

William Wood, MD

Emory University

• Globally recognized for his contributions to breast cancer therapy
• First Academic Dean of the Pan-African Academy of Christian Surgeons (PAACS)
• Editor-in-Chief of the renowned peer-review journal *Oncology*

Robert Ozols, MD

Fox Chase Cancer Center

• Established the worldwide standard regimen for patients with ovarian cancer
• Internationally recognized leader in ovarian cancer and chemotherapy research
• Former member of FDA Oncology Drug Advisory Committee

Charles Balch, MD, PhD (hc)

MD Anderson Cancer Center

• Global authority for melanoma and breast cancer
• One of the first doctors to identify prognostic factors for Stage I, II, and III melanoma
• Helped establish the current standard for melanoma surgery

Peter Wiernik, MD

St. Luke’s Roosevelt and Beth Israel Medical Centers

• Founder of the Comprehensive Cancer Center at Our Lady of Mercy Medical Center in NY
• Leader in hematology research
• Listed in Marquis’ “Who’s Who”